Abstract
We examined reverse redistribution (RR) of Tc-99m-tetrofosmin after a single injection in patients with acute myocardial infarction (AMI). Tc-99m-tetrofosmin myocardial SPECT was performed in 28 patients with AMI 10–14 days after the onset. Myocardial images were obtained 30 min and 180 min after the injection of 740 MBq of Tc-99m-tetrofosmin. The left ventricular wall was divided into 9 segments. Regional myocardial uptakes of Tc-99m-tetrofosmin were scored by 4-point scoring (0 = normal, 1 = mildly reduced, 2 = moderately reduced, and 3 = defect). RR was defined as an increase of more than 1 in the regional score in images at 180 min. RR of Tc-99m-tetrofosmin was observed in 17 of 20 patients with direct PTCA and 3 of 8 patients without reperfused therapy. RR was observed in 61 of all 252 segments. Coronary angiography performed 1 month later revealed that the infarct-related artery was patent in 19 of 20 patients (95%) with RR and in 3 of 8 patients (37.5%) with persistent defects (PD) (p < 0.05). In segment-by-segment analysis, the incidence of regional wall motion abnormality 1 month later was reduced in regions with RR compared to those with PD (p < 0.0001). In conclusion, RR of Tc-99m-tetrofosmin was frequently observed in patients with successful direct PTCA. As the segments with RR showed signs of preserved function 1 month later, this phenomenon may reflect a salvaged myocardium in AMI.
Similar content being viewed by others
References
Tamaki N, Takahashi N, Kawamoto M, Torizuka T, Tadamura E, Yonekura Y, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease.J Nucl Med 35: 594–600, 1994.
Jain D, Wackers FJT, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.J Nucl Med 34: 1254–1259, 1993.
Zaret BL, Rigo P, Wackers FJT, Hendel RC, Braat SH, Iskandrian AS, et al. Myocardial perfusion imaging with99mTc tetrofosmin. Comparison to201Tl imaging and coronary angiography in a phase III multicenter trial.Circulation 91: 313–319, 1995.
Ohtsuki K, Sugihara H, Taniguchi Y, Umamoto I, Nakagawa T, Nakamura T, et al. Evaluation of myocardial perfusion and ventricular shape in hypertrophic cardiomyopathy using99mTc-tetrofosmin scintigraphy: comparison with201Tl myocardial scintigraphy.KAKU IGAKU (Jpn J Nucl Med) 31: 309–318, 1994.
Kinoshita N, Sugihara H, Nakamura T, Ito K, Azuma A, Maeda T, et al. A calculation of an index of the coronary flow reserve using exercise and rest myocardial SPECT with99mTc-tetrofosmin.KAKU IGAKU (Jpn J Nucl Med) 34: 45–48, 1997.
Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m-tetrofosmin.J Nucl Med 34: 1478–1484, 1993.
Sugihara H, Taniguchi Y, Kinoshita N, Nakamura T, Hirasaki S, Azuma A, et al. Reverse redistribution of Tc-99m-tetrofosmin in exercise myocardial SPECT in patients with hypertrophic cardiomyopathy.Ann Nucl Med 12: 287–292, 1998.
Sugihara H, Kinoshita N, Adachi Y, Taniguchi Y, Ohtsuki K, Hirasaki S, et al. Early and delayed Tc-99m-tetrofosmin myocardial SPECT in patients with left bundle branch block.Ann Nucl Med 12: 281–286, 1998.
Weiss AT, Maddahi J, Lew AS, Shah PK, Ganz W, Swan HJC, et al. Reverse redistribution of thallium-201: a sign of nontransmural myocardial infarction with patency of the infarct-related coronary artery.J Am Coll Cardiol 7: 331–336, 1986.
Biggi A, Farinelli M, Bruna C, Papaleo A, De Benedictis N, Camuzzini GF. Thallium-201 reverse redistribution at rest: a pattern of myocardial infarction.J Nucl Med Allied Sci 31: 331–336, 1987.
Takeishi Y, Sukekawa H, Fujiwara S, Ikeno E, Sasaki Y, Tomoike H. Reverse redistribution of Technetium-99m-sestamibi following direct PTCA in acute myocardial infarction.J Nucl Med 37: 1289–1294, 1996.
Mori T, Hayakawa M, Hattori K, Awano K, Masuda J, Inatome T, et al. Exercise β-methyl iodophenyl pentadecanoic acid (BMIPP) and resting thallium-201 delayed single photon emission computed tomography (SPECT) in the assessment of ischemia and viability.Jpn Circ J 60: 17026, 1996.
Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A, et al. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease.Am J Cardiol 72: 1015–1019, 1993.
Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-tetrofosmin. I: uptake into isolated adult rat ventricular myocytes and subcellular localization.J Nucl Cardiol 2: 317–326, 1995.
Younes A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A. Mechanism of uptake of technetium-tetrofosmin. II: uptake into isolated adult rat heart mitochondria.J Nucl Cardiol 2: 327–333, 1995.
Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m-tetrofosmin, Technetium-99m-MIBI and Thallium-201 uptake in rat myocardial cells.J Nucl Med 39: 266–271, 1998.
Fujiwara S, Takeishi Y, Atsumi H, Yamaki M, Takahashi N, Yamaoka M, et al. Prediction of functional recovery in acute myocardial infarction: Comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch.J Nucl Cardiol 5: 119–127, 1998.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sugihara, H., Nakagawa, T., Yamashita, E. et al. Reverse redistribution of Tc-99m-tetrofosmin in patients with acute myocardial infarction. Ann Nucl Med 13, 43–47 (1999). https://doi.org/10.1007/BF03165428
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03165428